Researchers have engineered an inhalable nanoparticle system that keeps a critical TB drug in the lungs longer, raising the possibility of less frequent dosing and fewer systemic side effects. Scientists at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo have created an inhalable treatment for tuberculosis (TB) that could ease […]